ClinicalTrials.Veeva

Menu

VEGA System® Study in the Total Knee Arthroplasty

B. Braun logo

B. Braun

Status

Enrolling

Conditions

Knee Arthroplasty

Treatments

Device: total knee prothesis VEGA System

Study type

Observational

Funder types

Industry

Identifiers

NCT02944409
AAG-O-H-1511

Details and patient eligibility

About

This post-market clinical follow-up study intends to investigate long-term functionality of the VEGA System®. The design of the VEGA System® is meant to provide the patient with more knee mobility compared to their pre-operative state.The endpoint is the revision of at least one of the prosthesis components

Enrollment

125 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Patient from 18 to 75 years old
  2. Patient is able to comply with follow-up requirements including postoperative self-evaluations.
  3. Patient requires a primary knee replacement.
  4. Patient has a diagnosis of osteoarthritis
  5. Patient has intact collateral ligaments.

Exclusion Criteria

  1. Vulnerable patient under legal protection
  2. Patients with inflammatory arthritis.
  3. Patients that have had a high tibial osteotomy or femoral osteotomy.
  4. Pregnancy

Trial contacts and locations

2

Loading...

Central trial contact

Remy Nizard

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems